KURA

Conviction 72HealthcareScan · Fri, Jun 26, 2026

KURA$10.89+5.12%

ResistanceSupportVol 14Insider sell

Vol MA14 1.58M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Kura Oncology, Inc.PHARMACEUTICAL PREPARATIONSwww.kuraoncology.com ↗

Price10.89

Change+5.12%

Gap-0.97%

Rel volume1.06×

Avg volume1.78M

Avg $ vol16.67M

SMA 209.47

SMA 509.51

SMA 2009.43

Price vs 50+14.50%

Price vs 200+15.54%

MA stackbullish

50/200 crossgolden · 4d

Supertrendup · 9.19

RSI (14)66

MACD hist0.18

MACD crossbull · 6d

Stoch %K / %D95 / 85

ADX (14)19

+DI / −DI30 / 15

RSI divergence—

MACD divergence—

ATR %+5.14%

ADR %5.63%

52w high12.14

52w low5.54

From 52w high-10.30%

Above 52w low+96.57%

New 52w highNo

SqueezeOff

Bollinger width31.44%

%B0.98

Donchian pos94.70%

Donchian high11.03

Donchian low8.39

AVWAP (52w high)9.51

vs AVWAP high+14.51%

AVWAP (52w low)9.31

vs AVWAP low+16.96%

OBV trendFlat

Chaikin MF (20)-0.14

Today vs 20d1.06×

Avg vol (14d)1.58M

Avg vol (20d)1.78M

Avg $ vol (20d)16.67M

Market cap—

RS 3m (vs SPY)+9.37%

RS 6m (vs SPY)-15.30%

RS line new highNo

Trend template6/8

Technical rank69.5

1 week+9.67%

1 month+6.35%

3 months+30.26%

6 months+0.93%

1 year+87.76%

YTD+5.37%

P/E-3.30

P/B8.52

P/S13.62

P/FCF-13.00

EPS-3.18

Div yield—

ROE-258.30%

ROA-42.70%

Debt/Eq0.09

Current6.15

EV/EBITDA—

Gross margin—

Net margin-412.95%

Rev growth25.24%

EPS growth-60.17%

Price target28.11

Target upside171.46%

Analyst ratingBuy

Institutional101.75%

Ent. value889.92M

Revenue18.27M

Net income-73.33M

Gross profit—

Free cash flow-70.7M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.77M

Employees260

ListedTue, Aug 25, 2015

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction72 / 100

Pattern quality—

Tech rank69.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.76

Support8.45

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KURA

All disclosures →

No recent disclosed trades by Congress in KURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KURA · 7 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Leoni Mollie Chief Medical Officer · Common Stock · 2026-06-18	Sell	84.93K	$834K	2026-06-18	2026-06-22
Hasnain Faheem Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
VASCONCELLES MICHAEL Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Szela Mary T Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Malley Thomas Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
SCHAFER CAROL Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Collins Helen Louise Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Parks Diane L. Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Powl Brian T. Chief Commercial Officer · Common Stock · 2026-05-21	Sell	10K	$110K	2026-05-21	2026-05-22
Powl Brian T. Chief Commercial Officer · Common Stock · 2026-05-19	Sell	339	$3K	2026-05-19	2026-05-20

SEC filings

EDGAR filings in KURA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.